Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Imipramine
Information provision antidepressants barriers and facilitators to deprescribing benzodiazepines and z-drugs gabapentinoids
Informed consent Discussing Deprescribing Benzodiazepines and Z-Drugs Recent Developments in the Understanding of Antidepressant Withdrawal Tapering Benzodiazepines and Z-Drugs in Practice Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Insomnia antidepressants benzodiazepines and z-drugs gabapentinoids
Licensed options for tapering antidepressants benzodiazepines and z-drugs gabapentinoids Practical Options for Prescribing Gradually Tapering Doses Tapering Guidance for Specific Antidepressants Why Deprescribe?
Liquid formulations antidepressants benzodiazepines and z-drugs gabapentinoids Practical Options for Prescribing Gradually Tapering Doses
Lofepramine
Longer-term use antidepressants benzodiazepines and z-drugs gabapentinoids
Lorazepam Buspirone Lorazepam Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Switching to Longer-Acting Benzodiazepines to Taper When and Why to Stop Benzodiazepines and Z-Drugs Withdrawal Symptoms During Benzodiazepine Maintenance Treatment
Lormetazepam Lormetazepam Switching to Longer-Acting Benzodiazepines to Taper
Maintenance treatment Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition Overview of Gabapentinoid Withdrawal Effects Specific Issues in Psychiatric Drug Withdrawal Switching to Longer-Acting Benzodiazepines to Taper When and Why to Stop Antidepressants Withdrawal Symptoms During Antidepressant Maintenance Treatment or Switching Medication
Major depressive disorder
Mania Management of Complications of Benzodiazepine and Z-Drug Discontinuation Psychological Aspects of Tapering Benzodiazepines and Z-Drugs When and Why to Stop Benzodiazepines and Z-Drugs
Manufacturers liquid preparations antidepressants benzodiazepines and z-drugs gabapentinoids Practical Options for Prescribing Gradually Tapering Doses
Medicines and Healthcare Products Regulatory Agency (MHRA) Adverse Effects of Antidepressants Discussing Deprescribing Gabapentinoids Practical Options for Prescribing Gradually Tapering Doses Practical Options in Prescribing Gradually Tapering Doses of Antidepressants When and Why to Stop Gabapentinoids
Memory antidepressants benzodiazepines and z-drugs
Micro-tapering antidepressants benzodiazepines and z-drugs gabapentinoids
Mirtazapine Adverse Effects of Antidepressants Factors Influencing Development of Withdrawal Effects Managing Complications of Antidepressant Discontinuation Mirtazapine Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Tapering Antidepressants Gradually
Mis-diagnosis of withdrawal effects antidepressants benzodiazepines and z-drugs Clinical Aspects of Psychiatric Drug Withdrawal distinguishing from other conditions gabapentinoids Mis-Diagnosis of Withdrawal Effects As Relapse
Misuse benzodiazepines and z-drugs gabapentinoids
Moclobemide
Monitoring withdrawal symptoms antidepressants benzodiazepines and z-drugs Further Topics gabapentinoids Tapering Psychiatric Drugs in Practice
monoamine oxidase (MAO) Factors Influencing Development of Withdrawal Effects Moclobemide Phenelzine Recent Developments in the Understanding of Antidepressant Withdrawal Stratfiying Risk of Antidepressant Withdrawal Tranylcypromine
Morbidity Adverse Effects of Antidepressants When and Why to Stop Benzodiazepines and Z-Drugs
Mortality risks Adverse Effects of Antidepressants Discussing Deprescribing Benzodiazepines and Z-Drugs Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids
National Institute for Health and Care Excellence (NICE) antidepressants benzodiazepines and z-drugs gabapentinoids Mis-Diagnosis of Withdrawal Effects As Relapse Practical Options for Prescribing Gradually Tapering Doses The Context for Deprescribing The Neurobiology of Tapering
National Institute on Drug Abuse (NIDA) Mis-Diagnosis of Withdrawal Effects As Relapse Physical Dependence vs Addiction in Use of Benzodiazepines and Z-Drugs Recent Developments in the Understanding of Antidepressant Withdrawal
Neurobiology antidepressants benzodiazepines and z-drugs Mis-Diagnosis of Withdrawal Effects As Relapse Pathophysiology of Psychiatric Drug Withdrawal Symptoms The Neurobiology of Tapering
Neuromuscular disorders Clinical Aspects of Antidepressant Withdrawal Discussing Deprescribing Benzodiazepines and Z-Drugs Discussing Deprescribing Gabapentinoids Variety of Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Neuropathic pain Tapering Gabapentinoids in Practice When and Why to Stop Gabapentinoids